110 related articles for article (PubMed ID: 30079960)
1. Inherited variation in the xenobiotic transporter pathway and survival of multiple myeloma patients.
Macauda A; Castelli E; Buda G; Pelosini M; Butrym A; Watek M; Kruszewski M; Vangsted AJ; Rymko M; Jamroziak K; Abildgaard N; Haastrup EK; Mazur G; Ríos R; Jurczyszyn A; Zawirska D; Dudziński M; Raźny M; Dutka M; Tomczak W; Suska A; Druzd-Sitek A; Marques H; Petrini M; Markiewicz M; Martinez-Lopez J; Ebbesen LH; Iskierka-Jażdżewska E; Sainz J; Canzian F; Campa D
Br J Haematol; 2018 Nov; 183(3):375-384. PubMed ID: 30079960
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in xenobiotic transporters ABCB1, ABCG2, ABCC2, ABCC1, ABCC3 and multiple myeloma risk: a case-control study in the context of the International Multiple Myeloma rESEarch (IMMEnSE) consortium.
Martino A; Campa D; Buda G; Sainz J; García-Sanz R; Jamroziak K; Reis RM; Weinhold N; Jurado M; Ríos R; Szemraj-Rogucka Z; Marques H; Szemraj J; Stein A; Kumar R; Orciuolo E; Gemignani F; Landi S; Goldschmidt H; Petrini M; Dumontet C; Canzian F; Rossi AM
Leukemia; 2012 Jun; 26(6):1419-22. PubMed ID: 22182917
[No Abstract] [Full Text] [Related]
3. Polymorphisms in regulators of xenobiotic transport and metabolism genes PXR and CAR do not affect multiple myeloma risk: a case-control study in the context of the IMMEnSE consortium.
Martino A; Sainz J; Manuel Reis R; Moreno V; Buda G; Lesueur F; Marques H; García-Sanz R; Ríos R; Stein A; Dumontet C; Gemignani F; Maria Rossi A; Landi S; Jurado M; Petrini M; Jamroziak K; Campa D; Canzian F
J Hum Genet; 2013 Mar; 58(3):155-9. PubMed ID: 23303387
[TBL] [Abstract][Full Text] [Related]
4. Multidrug resistance gene expression and ABCB1 SNPs in plasma cell myeloma.
Drain S; Flannely L; Drake MB; Kettle P; Orr N; Bjourson AJ; Catherwood MA; Alexander HD
Leuk Res; 2011 Nov; 35(11):1457-63. PubMed ID: 21705081
[TBL] [Abstract][Full Text] [Related]
5. Impact of genetic polymorphisms of drug transporters
Madejczyk AM; Canzian F; Góra-Tybor J; Campa D; Sacha T; Link-Lenczowska D; Florek I; Prejzner W; Całbecka M; Rymko M; Dudziński M; Orzechowska MJ; Jamroziak K
Front Oncol; 2022; 12():952640. PubMed ID: 36212403
[TBL] [Abstract][Full Text] [Related]
6. ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis.
Cotte S; von Ahsen N; Kruse N; Huber B; Winkelmann A; Zettl UK; Starck M; König N; Tellez N; Dörr J; Paul F; Zipp F; Lühder F; Koepsell H; Pannek H; Montalban X; Gold R; Chan A
Brain; 2009 Sep; 132(Pt 9):2517-30. PubMed ID: 19605531
[TBL] [Abstract][Full Text] [Related]
7. Expression quantitative trait loci of genes predicting outcome are associated with survival of multiple myeloma patients.
Macauda A; Piredda C; Clay-Gilmour AI; Sainz J; Buda G; Markiewicz M; Barington T; Ziv E; Hildebrandt MAT; Belachew AA; Varkonyi J; Prejzner W; Druzd-Sitek A; Spinelli J; Andersen NF; Hofmann JN; Dudziński M; Martinez-Lopez J; Iskierka-Jazdzewska E; Milne RL; Mazur G; Giles GG; Ebbesen LH; Rymko M; Jamroziak K; Subocz E; Reis RM; Garcia-Sanz R; Suska A; Haastrup EK; Zawirska D; Grzasko N; Vangsted AJ; Dumontet C; Kruszewski M; Dutka M; Camp NJ; Waller RG; Tomczak W; Pelosini M; Raźny M; Marques H; Abildgaard N; Wątek M; Jurczyszyn A; Brown EE; Berndt S; Butrym A; Vachon CM; Norman AD; Slager SL; Gemignani F; Canzian F; Campa D
Int J Cancer; 2021 Jul; 149(2):327-336. PubMed ID: 33675538
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in the heparanase gene in multiple myeloma association with bone morbidity and survival.
Andersen NF; Vogel U; Klausen TW; Gimsing P; Gregersen H; Abildgaard N; Vangsted AJ
Eur J Haematol; 2015 Jan; 94(1):60-6. PubMed ID: 24954766
[TBL] [Abstract][Full Text] [Related]
9. Association of genotypes and haplotypes of multi-drug transporter genes ABCB1 and ABCG2 with clinical response to imatinib mesylate in chronic myeloid leukemia patients.
Au A; Aziz Baba A; Goh AS; Wahid Fadilah SA; Teh A; Rosline H; Ankathil R
Biomed Pharmacother; 2014 Apr; 68(3):343-9. PubMed ID: 24581936
[TBL] [Abstract][Full Text] [Related]
10. Single nucleotide polymorphisms in ABCC2 and ABCB1 genes and their clinical impact in physiology and drug response.
Wada M
Cancer Lett; 2006 Mar; 234(1):40-50. PubMed ID: 16377077
[TBL] [Abstract][Full Text] [Related]
11. A comprehensive study of polymorphisms in ABCB1, ABCC2 and ABCG2 and lung cancer chemotherapy response and prognosis.
Campa D; Müller P; Edler L; Knoefel L; Barale R; Heussel CP; Thomas M; Canzian F; Risch A
Int J Cancer; 2012 Dec; 131(12):2920-8. PubMed ID: 22473764
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetic analysis of high-dose methotrexate treatment in children with osteosarcoma.
Hegyi M; Arany A; Semsei AF; Csordas K; Eipel O; Gezsi A; Kutszegi N; Csoka M; Muller J; Erdelyi DJ; Antal P; Szalai C; Kovacs GT
Oncotarget; 2017 Feb; 8(6):9388-9398. PubMed ID: 27566582
[TBL] [Abstract][Full Text] [Related]
13. Impact of MiRSNPs on survival and progression in patients with multiple myeloma undergoing autologous stem cell transplantation.
de Larrea CF; Navarro A; Tejero R; Tovar N; Díaz T; Cibeira MT; Rosiñol L; Ferrer G; Rovira M; Rozman M; Monzó M; Bladé J
Clin Cancer Res; 2012 Jul; 18(13):3697-704. PubMed ID: 22539802
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetic study of the impact of ABCB1 single-nucleotide polymorphisms on lenalidomide treatment outcomes in patients with multiple myeloma: results from a phase IV observational study and subsequent phase II clinical trial.
Jakobsen Falk I; Lund J; Gréen H; Gruber A; Alici E; Lauri B; Blimark C; Mellqvist UH; Swedin A; Forsberg K; Carlsson C; Hardling M; Ahlberg L; Lotfi K; Nahi H
Cancer Chemother Pharmacol; 2018 Jan; 81(1):183-193. PubMed ID: 29177954
[TBL] [Abstract][Full Text] [Related]
15. TLR4/TIRAP polymorphisms are associated with progression and survival of patients with symptomatic myeloma.
Bagratuni T; Terpos E; Eleutherakis-Papaiakovou E; Kalapanida D; Gavriatopoulou M; Migkou M; Liacos CI; Tasidou A; Matsouka C; Mparmparousi D; Dimopoulos MA; Kastritis E
Br J Haematol; 2016 Jan; 172(1):44-7. PubMed ID: 26564000
[TBL] [Abstract][Full Text] [Related]
16. A common variant within the HNF1B gene is associated with overall survival of multiple myeloma patients: results from the IMMEnSE consortium and meta-analysis.
Ríos-Tamayo R; Lupiañez CB; Campa D; Hielscher T; Weinhold N; Martínez-López J; Jerez A; Landi S; Jamroziak K; Dumontet C; Wątek M; Lesueur F; Reis RM; Marques H; Jurczyszyn A; Vogel U; Buda G; García-Sanz R; Orciuolo E; Petrini M; Vangsted AJ; Gemignani F; Försti A; Goldschmidt H; Hemminki K; Canzian F; Jurado M; Sainz J
Oncotarget; 2016 Sep; 7(37):59029-59048. PubMed ID: 27437873
[TBL] [Abstract][Full Text] [Related]
17. Associations of ABCB1, ABCC2, and ABCG2 polymorphisms with irinotecan-pharmacokinetics and clinical outcome in patients with advanced non-small cell lung cancer.
Han JY; Lim HS; Yoo YK; Shin ES; Park YH; Lee SY; Lee JE; Lee DH; Kim HT; Lee JS
Cancer; 2007 Jul; 110(1):138-47. PubMed ID: 17534875
[TBL] [Abstract][Full Text] [Related]
18. ABCC2 polymorphisms and survival in the Princess Margaret cohort study and the NCIC clinical trials group BR.24 trial of platinum-treated advanced stage non-small cell lung cancer patients.
Cuffe S; Azad AK; Qiu X; Qiu X; Brhane Y; Kuang Q; Marsh S; Savas S; Chen Z; Cheng D; Leighl NB; Goss G; Laurie SA; Seymour L; Bradbury PA; Shepherd FA; Tsao MS; Chen BE; Xu W; Liu G
Cancer Epidemiol; 2016 Apr; 41():50-6. PubMed ID: 26816351
[TBL] [Abstract][Full Text] [Related]
19. Identification of miRSNPs associated with the risk of multiple myeloma.
Macauda A; Calvetti D; Maccari G; Hemminki K; Försti A; Goldschmidt H; Weinhold N; Houlston R; Andersen V; Vogel U; Buda G; Varkonyi J; Sureda A; Martinez Lopez J; Watek M; Butrym A; Sarasquete ME; Dudziński M; Jurczyszyn A; Druzd-Sitek A; Kruszewski M; Subocz E; Petrini M; Iskierka-Jażdżewska E; Raźny M; Szombath G; Marques H; Zawirska D; Chraniuk D; Halka J; Hove Jacobsen SE; Mazur G; García Sanz R; Dumontet C; Moreno V; Stępień A; Beider K; Pelosini M; Manuel Reis R; Krawczyk-Kulis M; Rymko M; Avet-Loiseau H; Lesueur F; Grząśko N; Ostrovsky O; Jamroziak K; Vangsted AJ; Jerez A; Tomczak W; Zaucha JM; Kadar K; Sainz J; Nagler A; Landi S; Gemignani F; Canzian F
Int J Cancer; 2017 Feb; 140(3):526-534. PubMed ID: 27718532
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in ABCG2, ABCC3 and CNT1 genes and their possible impact on chemotherapy outcome of lung cancer patients.
Müller PJ; Dally H; Klappenecker CN; Edler L; Jäger B; Gerst M; Spiegelhalder B; Tuengerthal S; Fischer JR; Drings P; Bartsch H; Risch A
Int J Cancer; 2009 Apr; 124(7):1669-74. PubMed ID: 19107936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
